Method for treating hypocarbic diseases and states

FIELD: medicine, respiratory gymnastics.

SUBSTANCE: the present innovation deals with decreasing pulmonary ventilation in patient's endurable volume, controlling the rate for carbon dioxide (CO2) gain in expired air and maintaining the rate of its increase. Moreover, decreased pulmonary ventilation should be performed both at the state of rest and while doing physical loading, one should maintain the rate of CO2 gain in expired air being not above 2 mm mercury column/d at the state of rest and 11 mm mercury column in case physical loading to achieve the level of 32.1 mm mercury column at removing vivid symptoms of the disease and 55 mm mercury column in case of prolonged clinical remission. The method enables to improve therapy of hypocarbic diseases and states due to removing CO2 deficiency.

EFFECT: higher efficiency of therapy.

4 ex, 3 tbl

 

The invention relates to the field of medicine and is intended for the treatment of hypocarbia by reducing ventilation in portable volume at rest and during physical load when subject to the control of CO2in the exhaled breath of the patient air.

The prior art method of treatment of removepackage bronchial asthma copyright certificate №1067640, IPC 7 A61 M 1/00, which is characterized by reduced ventilation in the portable patient volume, control the concentration of carbon dioxide in the exhaled air of the patient and maintaining the speed of its increase no more than 3-7 mm Hg per day up to a level 45-55 mm Hg

Despite the advantages of the above-mentioned method, it is effective in milder forms of asthma.

A known method according to the author's certificate No. 1067640 adopted as the prototype of the claimed invention.

An object of the invention is to increase the effectiveness of treatment of hypocarbia by eliminating deficit of CO2in General.

The problem is solved in that in the method of treatment gipotermiceski diseases and conditions characterized by reduced ventilation in the portable patient volume, control the speed of the increase of carbon dioxide (CO2) in the exhaled air and maintaining the speed of its increase, according to the SNO invention reduce ventilation in the portable patient volume is carried out at rest and during physical load, at the same time supporting growth rate CO2breath, not exceeding 2 mm Hg per day at rest, and 11 mm Hg during exercise to achieve the level of 32.1 mm RT Art. when Troubleshooting a clear symptom of the disease and 55 mm Hg with long-term clinical remission.

The invention is illustrated by clinical examples.

The CO2in the exhaled air is determined by known methods. Apply a known standard device “Capnograph and test method for measuring CO2based on the method according to the author's certificate No. 1593527.

Clinical examples.

Example 1 (an example of treatment of alveolarectasia):

Patient P., aged 6. Diagnosis: Atopic bronchial asthma, severe form. NAM II. Chronic vasomotor rhinitis. Polyvalent Allergy.

Was admitted with complaints: constant shortness of breath, against which there were 6-7 asthma attacks, mostly with little exertion and at night; constant cough with difficult to spit sputum, sometimes reaching the point of vomiting; nasal breathing; weakness, poor sleep, tearfulness, irritability; itching; constipation.

Objectively admission: State of moderate severity. Nasal breathing is practically absent, remote wheezing, severe expiratory dyspnea. Skin p is a pale roofs. Auscultation: scattered high and nicotinamine dry rales, wet medium sized bubble rales over the lung tissue. Percutane-sound box. BH=30 min. Heart tones are muffled, HR=118 per minute, regular rhythm, BP=100/60 mm RT. senior Language - geographic. The belly is painful to palpation in the epigastrium and right hypochondrium. KP=3 seconds, RNO2=22.4 mm RT. Art.

Method learned immediately after 10-15 minutes took asthmatic condition: improved nasal breathing, decreased cough and shortness of breath, heart rate decreased to 100 per minute. Auscultation - decreased the amount of dry vysokovoljnykh wheeze, BH=20 min. 6-day treatment of KP increased to 9-10 seconds, and the level of pCO2in the alveoli 27.3 up to 31.8 mm RT. Art. While asthma attacks ceased completely, eliminated the need for medication, the boy became much more active, increased tolerance to physical load.

The 14-day treatment of KP increased to 20 seconds, and RNO2to 35.6 mm RT. century, which was accompanied by a further decrease in shortness of breath, normalization of sleep, improve appetite, reduce overall weakness and sweating.

In the future when reaching KP 30-40 seconds disappeared clinical manifestations of allergies, including reaction to smells. During the inspection: satisfactory Condition. Skin and visible mucous is made clean, the regular color. In the lungs the breath vesicular, n/harsh tone. BH=14 min. Heart tones are clear, HR=80 min, BP=90/60 mm RT. senior Language is clean, damp. Abdomen - soft, b/painful.

During follow-up after 6 months of exacerbations of bronchial asthma or any allergic reactions were not observed, achieved stable remission of the disease.

IndicatorsKP=3 secondsKP=40 seconds
VC liter0,31,5
RNO2mm RT. article27,335,6
Complete blood count:  
- leukocytes9,2×10/l7,2×10/l
- eosinophils233
- p/I15
- /I4054
- lymphocytes3137
- monocytes51
- ESR9 mm/h9 mm/h

On radiographs of the chest when KP=40 seconds (one month after the start of treatment): Lung fields in n/departments increased transparency, the roots are sealed, tyazhistye. Infiltrate the data and focal changes are not identified. Heart - without features.

Example 2 (example of treatment of alveologenic):

Patient N., for 8 years. Diagnosis: Mixed bronchial asthma, lung during. NAM 1.

Adenoidectomy in 2002, Chronic residential vasomotor rhinitis, acute stage. Atopic dermatitis. Chronic gastritis, remission.

Admitted with complaints: the lack of nasal breathing, mucous discharge from the nose, cough slimy character during the day, worse at night.

Objectively upon receipt: satisfactory Condition. The skin is clean, the skin of her cheeks dry. Nasal breathing is absent. Swelling of face, redness of conjunctiva. In the lungs, breathing hard, diffuse dry visokomoralniye wheezing in small numbers over the whole lung tissue. BH=18 per minute. Heart tones are clear, heart rate=100 / minute, regular rhythm, BP=100/60 mm RT. senior Abdomen - soft, b/painful. MP=12 seconds, RNO2=29 mm RT. Art.

From the first days of practice nasal breathing is restored to the decreasing depth of breathing during exercise during exercise.

After 7 days: nasal breathing free, discharge from the nose there. Still coughing and nasal breathing during the night. MP increased to 16 seconds, and RNO2- up to 30 mm RT. Art.

After 14 days: no complaints.

Objective: State the satisfaction with WriteLine. The skin is clean. Nasal breathing is free. In the lungs vesicular breathing, wheezing no. BH=14 min. Heart tones are clear, HR=90 / minute, regular rhythm, BP=90/60 mm RT. senior Abdomen - soft, b/painful. MP=20 seconds, RNO2=32.1 mm RT. Art.

IndicatorsMP=12 secondsMP=20 seconds
Complete blood count:  
- leukocytes8,9×10/l4,5×10/l
- eosinophils74
- p/I61
- /I5463
- lymphocytes3027
- monocytes35
- ESR2613
RNO2mm RT. Art.2932,1

Example 3 (example of treatment of alveolarectasia):

Patient K., age 9. Diagnosis: Bronchial asthma, mixed shape, medium-heavy during the acute phase. Polyvalent Allergy to food, household allergens.

Chronic gastritis.

Complaints at admission: dry, paroxysmal cough, worse at night, shortness of breath with minimal exertion, Pris the UPA suffocation at night and up to 2-3 times in the daytime.

Objectively admission: State of moderate severity. The skin is pure white. Marked cyanosis of nasolabial triangle. In the lungs, breathing hard, scattered multiple visokomoralniye rales over the lung tissue. BH=24 per minute. Heart tones somewhat muted, HR=120 min. Otherwise - without features. MP=3 seconds, RNO2=22.4 mm RT. Art.

In the first hour of practice the pause grew to 9 seconds, RNO2- up to 28 mm RT. senior Attack was arrested.

After 6 months: Feeling good, but still coughing when errors in diet. MP=70 seconds, RNO2=47 mm RT. Art. the Last 4 months of drugs does not apply.

IndicatorsMP=3 secondsMP=70 seconds
Complete blood count:  
- Leukocytes5,27,06
- p/I--
- /I42,034,7
- lymphocytes41,249,6
- monocytes8,47,5
- eosinophils8,05,1
- basophils0,40,4
The number of immunoglob the Linova:   
- IgG (IU/ml)102174
- IgA (IU/ml)138160
IgM (IU/ml)9573
IgE (IU/ml)2929
- IgD (IU/ml)--
Lymphocytic immunity:  
- the content of T-lymphocytes60,0%63,5%
- the content of T-helpers35,3%46,4%
- the content of T-suppressors29,2%19,2%
- immunoregulatory index1,22,4
- natural killer cells9,9%14,2%
- B-lymphocytes 4,6%
- activated lymphocytes expressing receptors 3,6%
- mononuclear cells 91,2%
- HLA-DR+(monocytes, b-lymphocytes, activated T-lymphocytes) 6,2%
Phagocytic activity of neutrophils:  
- Spontaneous in USD0,16 0,29
Induced in USD0,260,35
The stimulation index1,61,4
- Adhesion of neutrophils57,1%58,7%
Antioxidant status:  
the concentration of malonic aldehyde3.2 µmol/ml4.5 µmol/ml
the concentration of lactoferrin1.0 mg/ml1.0 mg/ml
the catalase activity982,0 $ 1074 $
- activity ceruloplasmin0,54 $ 0,56 $
factor1,71,6
oxidative-antioxidative balance  
Interferon status: - Spontaneous interferon<2<2
Alpha-interferon320320
Gamma-interferon3232
- Serum interferon<22
RNO2mm RT. Art.22,447

Example 4 (example of the treatment of removepackage):

Patient H., 67 years old. Diagnosis: ischemic heart disease, Steneker the Oia voltage and the rest FK, postinfarction cardiosclerosis (krupnooptovyj myocardial infarction). Hypertension stage III, arterial hypertension 3rd degree. MK IIA. Dyscirculatory encephalopathy II degree complex Genesis (arterial hypertension and cerebral atherosclerosis). Effects of acute disorders of cerebral circulation in the right hemisphere.

Complaints at admission: anginalnomu bouts at light load and at rest, dizziness, frequent loss of orientation in space. Accepts up to 15 tablets of Nitroglycerin, Sustak-Forte up to 4 tablets per day, Cordarone 0.2 to 3 times per day.

KP at entry 3 seconds, RNO2- 22.4 mm RT. Art.

After 21 days: KP=15 seconds, RNO2- 29 mm RT. Art. Feel good, angina attacks only occur when excessive physical activity, normalized HELL. Nitropreparaty takes pain in the heart area.

After 3 months: Completely stopped the medication. Pain in the heart worry no more 1-3 times per month, reduced by the method. Runs fast walk 10-15 miles a day, can run 100-200 meters.

After 1 year: KP=35 seconds, RNO2=39 mm RT. Art.

ECG (+) speaker: “T” (-) in leads V2-V4 changed to “T” (+) in these derivations.

Previously for the treatment of the above diseases method was applied Leche is tion of removepackage (copyright certificate C.P. Buteyko No. 1067640), the essence of which is that for cure for bronchial asthma, you need to normalize the CO2in the blood, and for moderate and severe forms of bronchial asthma CO2in the blood and so above normal. Therefore, the use of the “old” way limited to mild forms of bronchial asthma, in which there is a shortage of CO2in the alveoli and the blood.

Thus, both methods allow to treat mild bronchial asthma and other above-listed diseases, and the “new” method (treatment of hypocarbia) allows to treat mild, moderate and severe forms of asthma and all other diseases (i.e. diseases caused by deficiency of CO2in this case, in the alveolar air of alveolarectasia). This invention is the Buteyko Method is a method of treatment of hypocarbia, which allows to achieve long-term remission for the above diseases.

Get rid of hypocarbia leads to the cure of the following diseases:

- Acute (pneumonia, bronchitis...) and chronic respiratory diseases - COPD: chronic obstructive bronchitis, bronchial asthma (at any stage and any form of course), emphysema, diffuse and focal pneumosclerosis, bronchiectasis;

- Diseases of cardiovascular system: hypertonics what I disease, coronary heart disease (at any stage and in any form);

Allergic diseases: chronic vasomotor rhinitis, pollinosis, urticaria, atopic dermatitis, etc.;

Secondary immunodeficiency States;

- Diseases of the gastrointestinal tract: chronic gastroduodenitis, peptic ulcer and 12-PC, chronic cholecystitis, chronic pancreatitis, etc.

The method of treatment gipotermiceski diseases and conditions characterized by reduced ventilation in the portable patient volume, control the speed of the increase of carbon dioxide (CO2) in the exhaled air and maintaining the speed of its increase, characterized in that the reduction of ventilation in the portable patient volume is carried out at rest and during physical load, supporting growth rate CO2breath, not exceeding 2 mm Hg per day at rest, and 11 mm Hg during exercise to achieve the level of 32.1 mm Hg when Troubleshooting striking symptoms of the disease and 55 mm Hg with long-term clinical remission.



 

Same patents:

FIELD: medical equipment, applicable for curative prophylaxis and for drug therapy of patients with bronchopulmonary diseases.

SUBSTANCE: the respiratory simulator consists of a mouthpiece - air conduit, casing with a cover, ball and a seat with a central hole making up a check valve. The check valve is made for closing at an expiration, its seat is made inside the casing in the form of a tapered recess in it and a central hole, by-pass channels are additionally made in the casing, a perforated diaphragm for limiting the ball motion is installed under the ball. The by-pass channels are made for adjustment of their area at an expiration or at an inhale, or simultaneously at an expiration and inhale and have a means for adjustment of the area of the by-pass channels. The means for adjustment of the area of the by-pass channels is made in the form of combined radial holes in the casing and ring and/or in the cover, and the cover and/or ring are made for restricted turning relative to the casing. The perforated diaphragm is made for tightening of the ball to the seat.

EFFECT: enhanced efficiency of treatment and simplified construction of the simulator.

14 cl, 16 dwg

The invention relates to medicine, obstetrics, and can be used to increase nonspecific resistance of the pregnant woman to the generic act

The invention relates to medical equipment, namely to devices to prevent the possibility of creating hypoxic mixtures in anesthesia devices by limiting the minimum oxygen concentration
The invention relates to medicine, in particular to prevention, and can be used to prevent the risk of stroke in patients with transient disorders of cerebral circulation in a state of depression and sleep disorders

Complex first aid // 2240143
The invention relates to medical equipment and can be used in extreme situations

The invention relates to medical equipment for the treatment and prevention of respiratory diseases

The invention relates to medical equipment

The invention relates to medicine and can be used for regeneration of medical xenon used in gazenergeticheskaya mixtures used in anaesthesia and inhalation devices

The invention relates to medicine and can be used for regeneration of medical xenon used in gazenergeticheskaya mixtures used in anaesthesia and inhalation devices
The invention relates to medicine, in particular to the prevention and rehabilitation, and can be used to increase nonspecific resistance of the organism

FIELD: medical equipment, applicable for curative prophylaxis and for drug therapy of patients with bronchopulmonary diseases.

SUBSTANCE: the respiratory simulator consists of a mouthpiece - air conduit, casing with a cover, ball and a seat with a central hole making up a check valve. The check valve is made for closing at an expiration, its seat is made inside the casing in the form of a tapered recess in it and a central hole, by-pass channels are additionally made in the casing, a perforated diaphragm for limiting the ball motion is installed under the ball. The by-pass channels are made for adjustment of their area at an expiration or at an inhale, or simultaneously at an expiration and inhale and have a means for adjustment of the area of the by-pass channels. The means for adjustment of the area of the by-pass channels is made in the form of combined radial holes in the casing and ring and/or in the cover, and the cover and/or ring are made for restricted turning relative to the casing. The perforated diaphragm is made for tightening of the ball to the seat.

EFFECT: enhanced efficiency of treatment and simplified construction of the simulator.

14 cl, 16 dwg

FIELD: medicine, respiratory gymnastics.

SUBSTANCE: the present innovation deals with decreasing pulmonary ventilation in patient's endurable volume, controlling the rate for carbon dioxide (CO2) gain in expired air and maintaining the rate of its increase. Moreover, decreased pulmonary ventilation should be performed both at the state of rest and while doing physical loading, one should maintain the rate of CO2 gain in expired air being not above 2 mm mercury column/d at the state of rest and 11 mm mercury column in case physical loading to achieve the level of 32.1 mm mercury column at removing vivid symptoms of the disease and 55 mm mercury column in case of prolonged clinical remission. The method enables to improve therapy of hypocarbic diseases and states due to removing CO2 deficiency.

EFFECT: higher efficiency of therapy.

4 ex, 3 tbl

Air duct device // 2245725

FIELD: medical engineering.

SUBSTANCE: device has curved flexible air-conducting tube and mask segment. The mask segment is shaped to completely fit to the area above the laryngeal orifice. Supporting member has a set of thin flexible ribs branching out from core member stretching from opening area. Having the air duct device mounted, the flexible ribs thrust against the pharyngeal side of cricoid laryngeal cartilage immediately under the esophagus. The mask segment is fixed and thrusts against hard surface without injuring soft esophageal tissues. Versions of present invention differ in means for fixing around the laryngeal orifice of a patient.

EFFECT: enhanced effectiveness of lung ventilation in unconscious state.

14 cl,8 dwg

FIELD: medical engineering.

SUBSTANCE: device has curved tube, cover, shield, metal cylinder, flexible plate and curved wire. Flexible curved tube is attached to one shield side and ring-shaped bead pressed with the cover is on the other side. One end of metal cylinder is beveled at an angle of 45° and the other one has thin rim. The flexible plate is shaped as the beveled cylinder base. The curved wire is attached to the plate with one end. The flexible tube has oval opening in the maximum curvature region, which area is equal to trachea cross-section area. Metal cylinder is enclosed in the flexible tube and rests with its rim upon the ring-shaped bead of the shield. The plate is mounted on the beveled base and attached to external surface of the cylinder with the other wire end.

EFFECT: enhanced effectiveness in creating voice; wide range of functional features; accelerated rehabilitation period.

1 dwg

FIELD: medical engineering.

SUBSTANCE: device has measuring unit 1 having inlet and outlet tubes 2 and 3 and electronic unit for processing signals. The device has control valve 4 mounted on inlet tube 2. The electronic unit for processing signals has absolute pressure gage 5 mounted on xenon entry to the measuring unit, standardizing amplifier 6 of absolute pressure, the first differential pressure gage 7, the first standardizing amplifier 8 of differential pressure, the second differential pressure gage 9, the second standardizing amplifier 10 of differential pressure, switch 11, multiplier 12, analog-to-digital converter 13, digital xenon discharge flow indicator 14, voltage-to-frequency converter 15, xenon quantity counter and digital xenon quantity indicator. The measuring unit has at least two parallel capillary tubes. Capillary tubes inlet is connected to the inlet tube and the outlet is connected to the outlet tube.

EFFECT: improved operation characteristics.

7cl, 1 dwg

FIELD: medical engineering.

SUBSTANCE: device has chamber for accumulating carbon dioxide, bite-board and respiratory pipe. The chamber is manufactured as cylinder having conic bases arranged one in the other smoothly movable one relative to each other. The respiratory pipe with bite-board is available on one of external cylinder tips and single-acting valve with choker is available on the other tip allowing rotation for making resistance to expiration. Reservoir for collecting condensate is mounted on cylindrical surface the external cylinder. Pipe for taking air samples is available on distal external cylinder part cone base.

EFFECT: smoothly controlling expiration resistance and carbon dioxide concentration; enhanced effectiveness in separating air flows.

2 dwg, 1 tbl

FIELD: medical engineering.

SUBSTANCE: device has sensing elements built in into mask body so that, when being put on, all required sensing elements are set on patient. The mask has soft flexible material on its perimeter holding the sensing elements inside for making contact with patient skin and making tight sealing. Sensing elements are also available on mask body and corresponding straps or caps. The sensing elements are usable for controlling electromyogram, electroencephalogram, electro-oculogram and electrocardiogram, superficial blood pressure, temperature, pulse, blood oxygen, patient position, patient activity level, sound and patient gas pressure in the mask.

EFFECT: wide range of functional applications.

31 cl, 7 dwg

FIELD: medicine; medical engineering.

SUBSTANCE: method involves applying diaphragmatic respiration with resistance to expiration. Overpressure equal to the resistance is created at inspiration stage. Breathing is carried out in usual pace in alternating A-type cycles as atmospheric air inspiration-expiration and B-type cycles as exhaled gas inspiration-expiration. Time proportion of breathing with exhaled gas to atmospheric air respiration is initially set not greater than 1. The value is gradually increased and respiration depth is reduced as organism adaptation to inhaled oxygen takes place, by increasing the number of B-type cycles and reducing the number of A-type cycles. Device has reservoir attached to mouth with individually selected expiration resistance. The reservoir has features for supporting gas overpressure at inspiration stage equal to one at expiration stage.

EFFECT: enhanced effectiveness of treatment; reduced volition effort required for training; improved operational functionality characteristics.

4 cl, 2 dwg

FIELD: pulmonology, intensive care, and reanimation techniques.

SUBSTANCE: two bronchial tubes are used, one being led through translaringal (nasobronchial or orobronchial) way into right or left bronchus and the other tube through trancheostomic hole led into principal bronchus on the opposite side thereby disengaging lungs below trachea bifurcation.

EFFECT: enabled access to respiratory tract of patient with damaged segment of trachea disconnected from respiration act in order to provide most favorable conditions for performing selective pulmonary ventilation.

1 dwg, 2 tbl, 3 ex

FIELD: urology.

SUBSTANCE: treatment course including 15-20 daily procedures consisting of 30-min respiration with hypoxic gas mixture is proposed. Oxygen level in such hypoxic gas mixture is stepwise lowered from one to the next session during first 4-7 days of normobaric hypoxic therapy from 16-17% to 12%. Normobaric hypoxic therapy is included into complex therapy of disease in decayed acute phase or unstable remission phase, or normobaric hypoxic therapy is employed when principal treatment is completed in case of severe progress of disease or before principal treatment course in case of asymptomatic clinical course or in remission phase.

EFFECT: prolonged remission period, reduced doses of drugs, increased fertility in patients.

5 cl, 3 tbl, 3 ex

Up!